Related Experiment Videos
Clinical features of MELAS and mitochondrial DNA mutations
1Department of Ultrastructural Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, Japan.
Abstract:
MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes) is a distinct disorder characterized clinically by repeated strokelike attacks mostly beginning in childhood. We have paid special attention to the blood vessel abnormality seen in most biopsied muscle, in terms of the strokelike episodes in MELAS. The 3243 mutation in 80% of the typical MELAS patients has also been found in patients differing from the MELAS phenotype. Because we have examined muscle biopsies in 94 MELAS or 3243-positive patients, it is worthwhile to summarize the clinical and pathological findings and to prove the discrepancy between phenotype and genotype. This may be a starting point for further discussion of the pathomechanism and so toward further understanding of the disease itself.
Insights
Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) involves blood vessel abnormalities. The common 3243 mutation presents varied symptoms, highlighting a genotype-phenotype discrepancy in MELAS patients.
Area of Science:
- Neurology
- Genetics
- Mitochondrial Diseases
Background:
- Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS) is a severe neurological disorder.
- Characterized by recurrent strokelike episodes, often starting in childhood.
- Muscle biopsy frequently reveals vascular abnormalities linked to strokelike episodes.
Purpose of the Study:
- To summarize clinical and pathological findings in MELAS patients.
- To investigate the discrepancy between genotype (3243 mutation) and phenotype in MELAS.
- To provide a basis for understanding MELAS pathomechanism.
Main Methods:
- Examination of muscle biopsies from 94 patients with MELAS or the 3243 mutation.
- Clinical assessment of patients.
- Pathological analysis of muscle tissue.
Main Results:
- The 3243 mutation is present in 80% of typical MELAS patients.
- The 3243 mutation was also identified in patients with phenotypes distinct from classic MELAS.
- Observed discrepancies between the genetic mutation and the clinical presentation.
Conclusions:
- A significant genotype-phenotype discrepancy exists in MELAS.
- Further research into pathomechanisms is needed for better understanding and treatment.
- Understanding this discrepancy is crucial for advancing MELAS research.